Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Bermuda.
Press releases published on July 14, 2025
Newsmatics to Host Global News Tech Workshops and AI Strategy Sessions in Prague
EIN Presswire
·
July 14, 2025
Week-long event brings together global teams to advance products like EIN Presswire, Perspectify, and the Newsmatics News Index through strategy workshops. WASHINGTON , DC, UNITED STATES, July 14, 2025 /EINPresswire.com/ -- News tech powerhouse …
Sanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025)
GlobeNewswire
·
July 14, 2025
Sanuwave is pleased to announce preliminary revenues of $10.1 million to $10.2 million for the second quarter ended June 30, 2025. This represents the highest Q2 quarterly revenues in Company history. Q2 2025 revenue increased between 41% and 42% compared …
Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program
GlobeNewswire
·
July 14, 2025
Pilot program designed to provide real-world evidence in the use of Tissue Health Plus’ technology platform FORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical …
60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025
GlobeNewswire
·
July 14, 2025
Data from three independent clinical studies demonstrate utility of tafenoquine to treat acute canine babesiosis WASHINGTON, July 14, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a …
Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight
GlobeNewswire
·
July 14, 2025
New York, USA, July 14, 2025 (GLOBE NEWSWIRE) -- Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight The Waldenstrom macroglobulinemia market is witnessing steady growth driven by advances …
Survey: Public Health Workers Are Younger, Committed, and Burned Out
GlobeNewswire
·
July 14, 2025
Bethesda, Md., July 14, 2025 (GLOBE NEWSWIRE) -- Findings from the 2024 Public Health Workforce Interests and Needs Survey (PH WINS) provide a unique snapshot of the government public health workforce, including the evolving demographics, job …
The Foundation for Sarcoidosis Research Awards $450,000 to Support Early-Career Investigators Through the 2025 Fellowship Grant
GlobeNewswire
·
July 14, 2025
CHICAGO, July 14, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the three recipients of the 2025 FSR Early Career Fellowship Grant: William Lippitt, PhD, (University of Colorado Anschutz Medical Campus), Juan …
Ascentage Pharma Announces Pricing of Top-Up Placement
GlobeNewswire
·
July 14, 2025
ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) (“Ascentage” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in …
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
GlobeNewswire
·
July 14, 2025
SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and founded and led by Anne Wojcicki, today announced that it has completed the acquisition of the Personal Genome …
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
GlobeNewswire
·
July 14, 2025
Tevogen.AI’s model drastically reduces target analysis and has the potential to generate billions in cost savings across the healthcare system by streamlining early-stage drug discovery, reducing wet lab dependency, and accelerating timelines. Beyond cost …
BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis
GlobeNewswire
·
July 14, 2025
First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting antibiotic-resistant lung infections in Cystic Fibrosis patients; topline results are expected in Q1 2026 Prior Phase 1b/2a efficacy …
Borvo EVAC™ System Demonstrates 100% Success Rate in Chronic Subdural Hematoma Clinical Cases Validated Across 5 Medical Centers
GlobeNewswire
·
July 14, 2025
MOUNTAIN VIEW, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Borvo Medical, a neurosurgical medtech startup and a portfolio company of NeuroTechnology Investors (NTI), today announced a 100% success rate across five medical centers using the FDA-cleared Borvo …
Pineapple, Inc. to Launch Real-World Asset Token Designed to Monetize Intellectual Property
GlobeNewswire
·
July 14, 2025
Tokenized IP platform built to enable access, utility, and engagement with Pineapple branded proprietary assets LOS ANGELES, CA, July 14, 2025 (GLOBE NEWSWIRE) -- Pineapple, Inc. (OTC: PNPL) (“Pineapple” or the “Company”) today announced its strategic …
NEXGEL and STADA AG Announce Expansion of Partnership for North America
GlobeNewswire
·
July 14, 2025
LANGHORNE, Pa., July 14, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced expanding its …
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
GlobeNewswire
·
July 14, 2025
Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase SCOTTSDALE, Ariz., July 14, 2025 (GLOBE NEWSWIRE) -- Journey …
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
GlobeNewswire
·
July 14, 2025
July 14, 2025 Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a …
Derma Fillers Market worth $7.32 billion by 2030 with 12.1% CAGR | MarketsandMarkets™.
GlobeNewswire
·
July 14, 2025
Delray Beach, FL, July 14, 2025 (GLOBE NEWSWIRE) -- The global derma fillers market, valued at US$3.74 billion in 2024 stood at US$4.13 billion in 2025 and is projected to advance at a resilient CAGR of 12.1% from 2025 to 2030, culminating in a forecasted …
Ciao Bella! Euro Summer Starts Right Here in Canada at Chopped Leaf
GlobeNewswire
·
July 14, 2025
Oakville, Ontario, Canada, July 14, 2025 (GLOBE NEWSWIRE) -- OAKVILLE, ON – Fresh, light and full of flavour, Chopped Leaf is introducing two new low-calorie, summer-fresh salads: the Antipasto Salad and Peach Caprese Salad, available across Canada …
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
GlobeNewswire
·
July 14, 2025
WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
GlobeNewswire
·
July 14, 2025
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) of an additional extension to …